Pfizer Inc. Files 10-Q for Q2 2024
Ticker: PFE · Form: 10-Q · Filed: 2024-08-05T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
Pfizer's Q2 2024 10-Q is in: financials and product performance detailed.
AI Summary
Pfizer Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational segments for the second quarter and the first half of the year. Specific financial figures and product-related revenues are presented, alongside information on common stock and additional paid-in capital.
Why It Matters
This filing provides investors and analysts with Pfizer's latest financial health and operational performance, crucial for understanding the company's trajectory in the pharmaceutical sector.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- N/A — Revenue (Specific revenue figures for Q2 2024 and H1 2024 are not explicitly stated in the provided text snippet.)
- N/A — Net Income (Specific net income figures for Q2 2024 and H1 2024 are not explicitly stated in the provided text snippet.)
- N/A — Earnings Per Share (Specific EPS figures for Q2 2024 and H1 2024 are not explicitly stated in the provided text snippet.)
Key Players & Entities
- Pfizer Inc. (company) — Filer of the 10-Q report.
- 20240630 (date) — End of the reporting period for the 10-Q.
- 20240805 (date) — Date the 10-Q was filed.
FAQ
What were Pfizer's total revenues for the second quarter of 2024?
The provided text does not contain specific revenue figures for the second quarter of 2024.
What is the company's reported net income for the first half of 2024?
The provided text does not contain specific net income figures for the first half of 2024.
Are there any significant changes in Pfizer's product segment revenues compared to the previous year?
The filing mentions product and royalty segments for Q2 2024 and H1 2024, but does not detail specific changes or comparisons to the prior year in this snippet.
What is the reported value of Pfizer's common stock as of June 30, 2024?
The filing indicates data related to common stock for the period ending June 30, 2024, but the specific value is not detailed in this text.
When was the company formerly known as Pfizer Charles & Co Inc.?
The date of the name change from Pfizer Charles & Co Inc. to Pfizer Inc. was September 8, 1971.
From the Filing
0000078003-24-000166.txt : 20240805 0000078003-24-000166.hdr.sgml : 20240805 20240805155443 ACCESSION NUMBER: 0000078003-24-000166 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 102 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240805 DATE AS OF CHANGE: 20240805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 241174580 BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 10-Q 1 pfe-20240630.htm 10-Q pfe-20240630 0000078003 12/31 2024 Q2 false xbrli:shares iso4217:USD iso4217:USD xbrli:shares pfe:operatingSegment xbrli:pure pfe:patent pfe:manufacturer pfe:treatmentCourse 0000078003 2024-01-01 2024-06-30 0000078003 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0000078003 pfe:NotesDue20271.000Member 2024-01-01 2024-06-30 0000078003 2024-07-31 0000078003 us-gaap:ProductMember 2024-04-01 2024-06-30 0000078003 us-gaap:ProductMember 2023-04-03 2023-07-02 0000078003 us-gaap:ProductMember 2024-01-01 2024-06-30 0000078003 us-gaap:ProductMember 2023-01-01 2023-07-02 0000078003 2024-04-01 2024-06-30 0000078003 2023-04-03 2023-07-02 0000078003 2023-01-01 2023-07-02 0000078003 us-gaap:RoyaltyMember 2024-04-01 2024-06-30 0000078003 us-gaap:RoyaltyMember 2023-04-03 2023-07-02 0000078003 us-gaap:RoyaltyMember 2024-01-01 2024-06-30 0000078003 us-gaap:RoyaltyMember 2023-01-01 2023-07-02 0000078003 2024-06-30 0000078003 2023-12-31 0000078003 us-gaap:CommonStockMember 2024-03-31 0000078003 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000078003 us-gaap:TreasuryStockCommonMember 2024-03-31 0000078003 us-gaap:RetainedEarningsMember 2024-03-31 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000078003 us-gaap:ParentMember 2024-03-31 0000078003 us-gaap:NoncontrollingInterestMember 2024-03-31 0000078003 2024-03-31 0000078003 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000078003 us-gaap:ParentMember 2024-04-01 2024-06-30 0000078003 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000078003 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000078003 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000078003 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0000078003 us-gaap:CommonStockMember 2024-06-30 0000078003 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000078003 us-gaap:TreasuryStockCommonMember 2024-06-30 0000078003 us-gaap:RetainedEarningsMember 2024-06-30 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000078003 us-gaap:ParentMember 2024-06-30 0000078003 us-gaap:NoncontrollingInterestMember 2024-06-30 0000078003 us-gaap:CommonStockMember 2023-04-02 0000078003 us-gaap:AdditionalPaidInCapitalMember 2023-04-02 0000078003 us-gaap:TreasuryStockCommonMember 2023-04-02 0000078003 us-gaap:RetainedEarningsMember 2023-04-02 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-02 0000078003 us-gaap:ParentMember 2023-04-02 0000078003 us-gaap:NoncontrollingInterestMember 2023-04-02 0000078003 2023-04-02 0000078003 us-gaap:RetainedEarningsMember 2023-04-03 2023-07-02 0000078003 us-gaap:ParentMember 2023-04-03 2023-07-02 0000078003 us-gaap:NoncontrollingInterestMember 2023-04-03 2023-07-02 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-03 2023-07-02 0000078003 us-gaap:CommonStockMember 2023-04-03 2023-07-02 0000078003 us-gaap:AdditionalPaidInCapitalMember 2023-04-03 2023-07-02 0000